Publication: Kinetic Control of Amyloidogenesis Calls for Unconventional Drugs To Fight Alzheimer's Disease
Kinetic Control of Amyloidogenesis Calls for Unconventional Drugs To Fight Alzheimer's Disease
Date
Date
Date
Citations
Caflisch, A. (2020). Kinetic Control of Amyloidogenesis Calls for Unconventional Drugs To Fight Alzheimer’s Disease. ACS Chemical Neuroscience, 11(2), 103–104. https://doi.org/10.1021/acschemneuro.9b00676
Abstract
Abstract
Abstract
Computer simulations had predicted that amyloid fibrillogenesis is governed by free energy barriers and kinetic traps (kinetic control), rather than the free energy of the final aggregates. The simulations suggested that the diversity in fibril morphologies can originate from variations in the number of protofilaments which has been confirmed by recent cryo-electron microscopy studies of amyloid-β fibrils derived from brain tissue of Alzheimer's patients. The kinetic control of fibril formation and polymorphism imply that chemical sub
Metrics
Downloads
Views
Additional indexing
Creators (Authors)
Volume
Volume
Volume
Number
Number
Number
Page range/Item number
Page range/Item number
Page range/Item number
Page end
Page end
Page end
Item Type
Item Type
Item Type
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Language
Language
Language
Publication date
Publication date
Publication date
Date available
Date available
Date available
ISSN or e-ISSN
ISSN or e-ISSN
ISSN or e-ISSN
OA Status
OA Status
OA Status
Free Access at
Free Access at
Free Access at
Publisher DOI
Metrics
Downloads
Views
Citations
Caflisch, A. (2020). Kinetic Control of Amyloidogenesis Calls for Unconventional Drugs To Fight Alzheimer’s Disease. ACS Chemical Neuroscience, 11(2), 103–104. https://doi.org/10.1021/acschemneuro.9b00676